Other Sport

Brock Lesnar suspended over failed UFC drug tests

2016-08-24 15:10
Brock Lesnar (supplied)

Cape Town - Former UFC heavyweight champion Brock Lesnar has been issued a temporary suspension by the Nevada Athletic Commission (NAC) after a meeting held on Tuesday.

The suspension stems from Lesnar's two failed UFC 200 drug tests. 

The 39-year old tested positive for the banned substance hydroxy-clomiphene, which is an anti-estrogen agent, in an out-of-competition drug test administered on June 28 as well as an in-competition test taken at UFC 200.

Lesnar faced and beat Mark Hunt in the night's co-main event via unanimous decision in his first fight in over 5-years. The WWE superstar is expected to receive a formal hearing with the NAC at a later date. If found guilty he faces a potential two-year suspension from both USADA and the NAC as well as a fine. 

"To my fans that watch me in the octagon, I thank them for their support," Lesnar told TMZ Sports. "This has been a bumpy road. I'm gonna get through this alright. And there will be a day, maybe, that they'll see me back in the octagon." 

Should Lesnar (6-3) be found guilty the suspension he receives will more than likely end his mixed martial arts career. 

Read more on:    ufc  |  mma
NEXT ON SPORT24X

What To Read Next

 

Read News24’s Comments Policy

Live Video Streaming
Video Highlights
Sport Talk

 
 
Men
Women
Love 2 Meet
Sport24 on Twitter

Follow Sport24 news on Twitter

Featured

Big month in the world of golf as the FedEx Cup concludes on the PGA Tour, the Race to Dubai gathers steam on the European Tour and the Sunshine Tour offers local golfers the chance to bank some cash. Oh, and not forgetting the USA v Europe Ryder Cup showdown at Hazeltine!

Latest blogs
Vote

How excited are you about the upcoming Olympic Games in Rio?

Twitter Follow Sport24 on Twitter

Facebook "Like" Sport24's Facebook page

WIN Enter and win with Sport24!

BlackBerry Stay in the loop on your BlackBerry

RSS Feeds Sport news delivered really simply.

 
There are new stories on the homepage. Click here to see them.